Evidence-Based Reviews
Evidence-Based Reviews
Antipsychotics and seizures: What are the risks?
Some agents may lower the seizure threshold, but higher-quality evidence is needed.
Evidence-Based Reviews
What’s new in transcranial magnetic stimulation
Recent developments have enhanced the benefits of this treatment.
Evidence-Based Reviews
Older-age bipolar disorder: A case series
Age-related variations in presentation, treatment response may warrant a different approach.
Evidence-Based Reviews
Antidepressants for chronic pain
Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.
Evidence-Based Reviews
Injectable extended-release naltrexone for opioid dependence: 3 studies
Here we summarize 3 studies to describe which patients might be optimal candidates for XR-NTX, its success in comparison with BUP-NX, and...
Evidence-Based Reviews
Can lifestyle modifications delay or prevent Alzheimer’s disease?
Evidence suggests combining lifestyle modifications may yield better cognitive outcomes.
Evidence-Based Reviews
Abuse of psychiatric medications: Not just stimulants and benzodiazepines
Anticholinergics, antidepressants, antipsychotics, and gabapentinoids may also be subject to misuse or abuse.
Evidence-Based Reviews
Botulinum toxin: Emerging psychiatric indications
Botulinum toxin has shown promising antidepressant effects, and might be helpful for several other indications.
Evidence-Based Reviews
Treating negative symptoms of schizophrenia
Few pharmacologic options, but evidence supports combining psychosocial interventions.
Evidence-Based Reviews
Treatment-resistant OCD: There’s more we can do
Augmentation strategies may help patients who don’t respond to first-line treatments.
Evidence-Based Reviews
Disruptive mood dysregulation disorder: A better understanding
Recognizing key differences in DMDD can help distinguish it from similar pediatric disorders.